Journal article icon

Journal article

Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia

Abstract:
Mutation or epigenetic silencing of the transcription factor C/EBPα is observed in ~10% of patients with acute myeloid leukemia (AML). In both cases, a common global gene expression profile is observed, but downstream targets relevant for leukemogenesis are not known. Here, we identify Sox4 as a direct target of C/EBPα whereby its expression is inversely correlated with C/EBPα activity. Downregulation of Sox4 abrogated increased self-renewal of leukemic cells and restored their differentiation. Gene expression profiles of leukemia-initiating cells (LICs) from both Sox4 overexpression and murine C/EBPα mutant AML models clustered together but differed from other types of AML. Our data demonstrate that Sox4 overexpression resulting from C/EBPα inactivation contributes to the development of leukemia with a distinct LIC phenotype. © 2013 Elsevier Inc.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.ccr.2013.09.018

Authors



Publisher:
Cell Press
Journal:
Cancer Cell More from this journal
Volume:
24
Issue:
5
Pages:
575-588
Publication date:
2013-01-01
DOI:
EISSN:
1878-3686
ISSN:
1535-6108


UUID:
uuid:05e65212-c680-4e57-b607-86d88fabf815
Local pid:
pubs:440202
Source identifiers:
440202
Deposit date:
2013-12-12

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP